Trials / Completed
CompletedNCT03208660
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
A Retrospective Multicenter Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is conducted to assess the retention rate of Fycompa when given in routine clinical care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fycompa | Oral suspension |
Timeline
- Start date
- 2017-04-07
- Primary completion
- 2019-03-15
- Completion
- 2019-03-15
- First posted
- 2017-07-05
- Last updated
- 2019-04-11
Locations
44 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03208660. Inclusion in this directory is not an endorsement.